Suppr超能文献

射血分数保留的心力衰竭研究重点:美国国立心肺血液研究所工作组总结。

Research Priorities for Heart Failure With Preserved Ejection Fraction: National Heart, Lung, and Blood Institute Working Group Summary.

机构信息

Northwestern University Feinberg School of Medicine, Chicago, IL (S.J.S.).

Mayo Clinic, Rochester, MN (B.A.B., M.M.R.).

出版信息

Circulation. 2020 Mar 24;141(12):1001-1026. doi: 10.1161/CIRCULATIONAHA.119.041886. Epub 2020 Mar 23.

Abstract

Heart failure with preserved ejection fraction (HFpEF), a major public health problem that is rising in prevalence, is associated with high morbidity and mortality and is considered to be the greatest unmet need in cardiovascular medicine today because of a general lack of effective treatments. To address this challenging syndrome, the National Heart, Lung, and Blood Institute convened a working group made up of experts in HFpEF and novel research methodologies to discuss research gaps and to prioritize research directions over the next decade. Here, we summarize the discussion of the working group, followed by key recommendations for future research priorities. There was uniform recognition that HFpEF is a highly integrated, multiorgan, systemic disorder requiring a multipronged investigative approach in both humans and animal models to improve understanding of mechanisms and treatment of HFpEF. It was recognized that advances in the understanding of basic mechanisms and the roles of inflammation, macrovascular and microvascular dysfunction, fibrosis, and tissue remodeling are needed and ideally would be obtained from (1) improved animal models, including large animal models, which incorporate the effects of aging and associated comorbid conditions; (2) repositories of deeply phenotyped physiological data and human tissue, made accessible to researchers to enhance collaboration and research advances; and (3) novel research methods that take advantage of computational advances and multiscale modeling for the analysis of complex, high-density data across multiple domains. The working group emphasized the need for interactions among basic, translational, clinical, and epidemiological scientists and across organ systems and cell types, leveraging different areas or research focus, and between research centers. A network of collaborative centers to accelerate basic, translational, and clinical research of pathobiological mechanisms and treatment strategies in HFpEF was discussed as an example of a strategy to advance research progress. This resource would facilitate comprehensive, deep phenotyping of a multicenter HFpEF patient cohort with standardized protocols and a robust biorepository. The research priorities outlined in this document are meant to stimulate scientific advances in HFpEF by providing a road map for future collaborative investigations among a diverse group of scientists across multiple domains.

摘要

射血分数保留的心力衰竭(HFpEF)是一种主要的公共卫生问题,其患病率正在上升,与高发病率和死亡率相关,并且由于缺乏有效的治疗方法,被认为是当今心血管医学中最大的未满足需求。为了应对这一具有挑战性的综合征,美国国立心肺血液研究所召集了一个由 HFpEF 专家和新的研究方法学专家组成的工作组,讨论研究差距,并确定未来十年的研究重点方向。在这里,我们总结了工作组的讨论,并提出了未来研究重点的关键建议。工作组一致认为,HFpEF 是一种高度综合的多器官、系统性疾病,需要在人类和动物模型中采用多管齐下的研究方法,以提高对 HFpEF 机制和治疗的理解。人们认识到,需要深入了解基本机制以及炎症、大血管和微血管功能障碍、纤维化和组织重塑的作用等方面的进展,并且最好能够从以下方面获得这些进展:(1)改进的动物模型,包括能够纳入衰老和相关合并症影响的大型动物模型;(2)深入表型的生理数据和人类组织库,这些资源可以供研究人员使用,以加强合作和研究进展;(3)利用计算进展和多尺度建模进行复杂、高密度数据的跨多个领域分析的新研究方法。工作组强调了基础、转化、临床和流行病学科学家之间以及跨器官系统和细胞类型之间相互作用的必要性,利用不同的研究领域或重点,并在研究中心之间进行合作。工作组讨论了建立一个协作中心网络,以加速 HFpEF 的病理生物学机制和治疗策略的基础、转化和临床研究,以此作为推进研究进展的一种策略。该资源将有助于对多中心 HFpEF 患者队列进行全面、深入的表型分析,并建立一个标准化的协议和强大的生物样本库。本文件中概述的研究重点旨在通过为跨越多个领域的不同类型科学家之间的未来合作研究提供路线图,来促进 HFpEF 的科学进展。

相似文献

1
Research Priorities for Heart Failure With Preserved Ejection Fraction: National Heart, Lung, and Blood Institute Working Group Summary.
Circulation. 2020 Mar 24;141(12):1001-1026. doi: 10.1161/CIRCULATIONAHA.119.041886. Epub 2020 Mar 23.
2
Evaluation of large animal models for preclinical studies of heart failure with preserved ejection fraction using clinical score systems.
Front Cardiovasc Med. 2023 Mar 23;10:1099453. doi: 10.3389/fcvm.2023.1099453. eCollection 2023.
3
Cellular and molecular pathobiology of heart failure with preserved ejection fraction.
Nat Rev Cardiol. 2021 Jun;18(6):400-423. doi: 10.1038/s41569-020-00480-6. Epub 2021 Jan 11.
4
Biomarkers in Heart Failure With Preserved Ejection Fraction: An Update on Progress and Future Challenges.
Heart Lung Circ. 2020 Jan;29(1):62-68. doi: 10.1016/j.hlc.2019.05.180. Epub 2019 Jul 5.
5
Epidemiology and clinical course of heart failure with preserved ejection fraction.
Eur J Heart Fail. 2011 Jan;13(1):18-28. doi: 10.1093/eurjhf/hfq121. Epub 2010 Aug 3.
6
The future of heart failure with preserved ejection fraction : Deep phenotyping for targeted therapeutics.
Herz. 2022 Aug;47(4):308-323. doi: 10.1007/s00059-022-05124-8. Epub 2022 Jun 29.
7
Precision Medicine for Heart Failure with Preserved Ejection Fraction: An Overview.
J Cardiovasc Transl Res. 2017 Jun;10(3):233-244. doi: 10.1007/s12265-017-9756-y. Epub 2017 Jun 5.
8
The aging heart in focus: The advanced understanding of heart failure with preserved ejection fraction.
Ageing Res Rev. 2024 Nov;101:102542. doi: 10.1016/j.arr.2024.102542. Epub 2024 Oct 12.
9
Heart Failure With Preserved Ejection Fraction: Heterogeneous Syndrome, Diverse Preclinical Models.
Circ Res. 2022 Jun 10;130(12):1906-1925. doi: 10.1161/CIRCRESAHA.122.320257. Epub 2022 Jun 9.

引用本文的文献

2
Prognostic Models in Heart Failure: Hope or Hype?
J Pers Med. 2025 Aug 1;15(8):345. doi: 10.3390/jpm15080345.
3
Integrated Systems Biology Identifies Disruptions in Mitochondrial Function and Metabolism as Key Contributors to HFpEF.
JACC Basic Transl Sci. 2025 Aug 15;10(9):101334. doi: 10.1016/j.jacbts.2025.101334.
4
Aging diastole - root cause for atrial fibrillation and heart failure with preserved ejection fraction.
J Cardiovasc Aging. 2024 Dec;4(4). doi: 10.20517/jca.2024.22. Epub 2024 Dec 23.
5
Cracking the Code of a Preclinical Rodent Model of HFpEF: The Mitochondrial Link.
JACC Basic Transl Sci. 2025 Aug 11;10(9):101357. doi: 10.1016/j.jacbts.2025.101357.

本文引用的文献

2
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
N Engl J Med. 2019 Oct 24;381(17):1609-1620. doi: 10.1056/NEJMoa1908655. Epub 2019 Sep 1.
3
Western Diet-Fed, Aortic-Banded Ossabaw Swine: A Preclinical Model of Cardio-Metabolic Heart Failure.
JACC Basic Transl Sci. 2019 Jun 24;4(3):404-421. doi: 10.1016/j.jacbts.2019.02.004. eCollection 2019 Jun.
4
Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: Understanding Mechanisms by Using Noninvasive Methods.
JACC Cardiovasc Imaging. 2020 Jan;13(1 Pt 2):245-257. doi: 10.1016/j.jcmg.2018.12.034. Epub 2019 Jun 12.
5
Nitrosative stress drives heart failure with preserved ejection fraction.
Nature. 2019 Apr;568(7752):351-356. doi: 10.1038/s41586-019-1100-z. Epub 2019 Apr 10.
6
The continuous heart failure spectrum: moving beyond an ejection fraction classification.
Eur Heart J. 2019 Jul 1;40(26):2155-2163. doi: 10.1093/eurheartj/ehz158.
7
Phenotypic Persistence in Heart Failure With Preserved Ejection Fraction.
Circ Heart Fail. 2019 Mar;12(3):e005956. doi: 10.1161/CIRCHEARTFAILURE.119.005956.
8
Heart Failure With Preserved Ejection Fraction Infrequently Evolves Toward a Reduced Phenotype in Long-Term Survivors.
Circ Heart Fail. 2019 Mar;12(3):e005652. doi: 10.1161/CIRCHEARTFAILURE.118.005652.
9
Myocardial Strain in the Assessment of Patients With Heart Failure: A Review.
JAMA Cardiol. 2019 Mar 1;4(3):287-294. doi: 10.1001/jamacardio.2019.0052.
10
Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
JACC Cardiovasc Imaging. 2019 Nov;12(11 Pt 2):2291-2301. doi: 10.1016/j.jcmg.2018.11.031. Epub 2019 Feb 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验